Effect of Aspirin Dose on Mortality and Cardiovascular Events in People with Diabetes: A Meta-Analysis

Aspirin Use Rates in Diabetes: A Systematic Review Cross-Sectional Study

(2012) Ernest H. Law et al.   Canadian Journal of Diabetes

Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Diabetes: A Meta-Analysis

(2010) Stavros Stavrakis et al.   AMERICAN JOURNAL OF THE MEDICAL SCIENCES

Aspirin for Primary Prevention of Cardiovascular Events in People With Diabetes: A position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation

(2010) M. Pignone et al.   DIABETES CARE

Role of aspirin in the primary prevention of cardiovascular disease in diabetes mellitus: a meta-analysis

(2010) Naveed Younis et al.   EXPERT OPINION ON PHARMACOTHERAPY

Aspirin for Prevention of Cardiovascular Events in a General Population Screened for a Low Ankle Brachial IndexA Randomized Controlled Trial

(2010) F. Gerald R. Fowkes   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Lack of benefits for prevention of cardiovascular disease with aspirin therapy in type 2 diabetic patients - a longitudinal observational study

(2009) Wilson Y Leung et al.   Cardiovascular Diabetology

Aspirin Is Associated With Reduced Cardiovascular and All-Cause Mortality in Type 2 Diabetes in a Primary Prevention Setting: The Fremantle Diabetes Study

(2009) G. Ong et al.   DIABETES CARE

Mortality Trends in Subjects With and Without Diabetes During 33 Years of Follow-up

(2009) S. P.O. Jansson et al.   DIABETES CARE

Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis

(2009) Chunyu Zhang et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

(2009)   LANCET

Does aspirin use reduce cardiovascular risk in diabetes?

(2009) John A. Colwell   Nature Reviews Endocrinology

Aspirin increases mortality in diabetic patients without cardiovascular disease: a Swedish record linkage study

(2009) Lennart Welin et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Aspirin Resistance

(2009) Udaya S. Tantry et al.   PROGRESS IN CARDIOVASCULAR DISEASES

Elderly patients undergoing major vascular surgery: Risk factors and medication associated with risk reduction

(2008) Harm H.H. Feringa et al.   ARCHIVES OF GERONTOLOGY AND GERIATRICS

Aspirin resistance and diabetes mellitus

(2008) R. Ajjan et al.   DIABETOLOGIA

Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 DiabetesA Randomized Controlled Trial

(2008) Hisao Ogawa   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION